Interagency Coordination in Drug Research and Regulation. hearings before the United States Senate Committee on Government Operations, Subcommittee on Reorganization and International Organizations, Eighty-Seventh Congress, second session, on Aug. 1, 9, 1962. Part 1 :

Reviews cooperative efforts among Federal and international agencies responsible for medical research on experimental drugs and regulation of pharmaceutical industry marketing practices. Includes review of thalidomide marketing and use.